Sea Buckthorn Lipids Randomized Trial: What the Evidence Says

Quick Answer

Sea Buckthorn Lipids Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 systematic review, 1 narrative review.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Hippophae rhamnoides Elaeagnaceae α β γ α β γ p 1 2 3 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 3 18 19 Sea buckthorn (SB), also known as, is a deciduous shrub rich in nutrients belonging to the family, mostly found in coastal areas, river banks and mountainous zones in Eastern Europe and Asia. [Hincu Maria Andrada (2026); evidence level 1]
• SB has a long history as a therapeutic substance, being used to treat different skin-associated health problems (it was used for skin repair, UV-photoprotection, in psoriasis, allergic and atopic dermatitis, acne, ichthyosis) for thousands of years in several different cultures. [Hincu Maria Andrada (2026); evidence level 1]
• Current challenges include a lack of standardization in extraction methods, a limited mechanistic understanding of bioactive interactions, and insufficient clinical evidence to substantiate health claims. [Jiang Xiaojing (2026); evidence level 3]
• Although this concentration is notably lower than the 30-35% typically found in tropical oils such as palm or coconut oil, PA remains integral to the unique therapeutic efficacy of SBSO. [Jiang Xiaojing (2026); evidence level 3]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For sea buckthorn lipids randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Hincu Maria Andrada (2026). Rosacea and Hippophae rhamnoides : A Phytonutrient Approach to Skin Repair (The Systematic Review). DOI: 10.3390/medicina62040676. PMCID: PMC13118053. PMID: 42075548. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13118053/
• Jiang Xiaojing (2026). From Nutritional Profile to Circular Bioeconomy: A Review of Sea Buckthorn Oil and By-Product Valorization. DOI: 10.3390/foods15111873. PMCID: PMC13256188. PMID: 42279660. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13256188/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.